ORAGRAFIN SODIUM
LOE ApproachingNDAORALCAPSULEPriority Review
Approved
Jun 1962
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 2m ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ORAGRAFIN SODIUM is an oral capsule contrast agent approved by Bracco in 1962 for diagnostic imaging purposes. The product is a small molecule iodinated compound used to enhance radiographic visualization of gastrointestinal structures. It represents a legacy diagnostic agent from the early pharmaceutical era with limited modern clinical application.
LOE Approaching
Minimal commercial activity with only 30% competitive pressure; expect minimal team size and focus on legacy patient maintenance rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
ORAGRAFIN SODIUM offers minimal career advancement opportunities due to its LOE-approaching lifecycle status and zero linked job openings. Professionals assigned to this product would focus on regulatory compliance, legacy patient support, and managed decline rather than growth or innovation.
Product Manager (Legacy)Sales Representative
Worked on ORAGRAFIN SODIUM at Bracco? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.